Item 8.01. Other Events.
As reported previously in Current Reports on Form 8-K filed by us on February
22, 2021 and March 16, 2021, we consummated the closings of our IPO on February
19, 2021 and March 3, 2021, selling 10,000,000 and 1,500,000 units to the
public, on those respective dates and generating aggregate gross proceeds of
$100,000,000 and $15,000,000 to the Company from those respective closings.
Substantially concurrently with the two closings of the IPO, we completed the
private sale (the "Private Placement") of 350,000 units and 30,000 units (the
"Private Placement Units"), respectively, in the aggregate, to Moringa Sponsor
US L.P. and EarlyBirdCapital, Inc. at a purchase price of $10.00 per Private
Placement Unit, generating aggregate gross proceeds to the Company of
$3,800,000.
Following the respective closings, a total of $100,000,000 and $15,000,000 were
deposited in Goldman Sachs money market funds and a JP Morgan Chase trust
account, respectively.
An audited balance sheet as of March 3, 2021 reflecting receipt of the proceeds
upon consummation of the IPO and the Private Placement has been issued by the
Company and is included as Exhibit 99.1 to this Current Report on Form 8-K/A.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Audited Balance Sheet, as of March 3, 2021
2
© Edgar Online, source Glimpses